International Committee on Mental Health in Cystic Fibrosis: Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus statements for screening and treating depression and anxiety

Thorax

Volumn 71, Issue 1, 2016, Pages 26-34

  Quittner, Alexandra L ^a   Abbott, Janice ^b   Georgiopoulos, Anna M ^c   Goldbeck, Lutz ^d   Smith, Beth ^e   Hempstead, Sarah E ^f   Marshall, Bruce ^g   Sabadosa, Kathryn A ^f   Elborn, Stuart ^h   Boyle, Michael ⁱ   Crossan, Amanda ^j   Gartner, Silvia ^k   Gerlach, Manfred ^l   Rounds, Jennifer ^f   Hug, Martin ^m   Kvam, Christopher ⁿ   Macias, Michelle ⁿ   Mueller, Amy ^o   Noordhoek, Jacquelien ^p   Ramchandi, Paul ^q   Reno, Kim ^r   Riekert, Kristin ⁱ   Uluer, Ahmet ^s   Zirbes, Jacquelyn ^t   more..

^a University of Miami   (United States)

^b UNIVERSITY OF CENTRAL LANCASHIRE   (United Kingdom)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d UNIVERSITY HOSPITAL ULM   (Germany)

^e UNIVERSITY AT BUFFALO   (United States)

^f DARTMOUTH INSTITUTE FOR HEALTH POLICY AND CLINICAL PRACTICE   (United States)

^g CYSTIC FIBROSIS FOUNDATION   (United States)

^h QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

ⁱ JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^j Northern Ireland Regional Adult Cystic Fibrosis Centre   (United Kingdom)

^k HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^l UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

^m UNIVERSITY OF FREIBURG   (Germany)

ⁿ MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^o HARTFORD HOSPITAL   (United States)

^p Dutch CF Foundation   (Netherlands)

^q IMPERIAL COLLEGE LONDON   (United Kingdom)

^r Pediatric Pulmonary and Cystic Fibrosis Care Center of Northwest Ohio   (United States)

^s BRIGHAM AND WOMEN S HOSPITAL   (United States)

^t STANFORD UNIVERSITY   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANXIETY; ARTICLE; CAREGIVER BURDEN; CLINICAL ASSESSMENT; CONSENSUS; CYSTIC FIBROSIS; DEPRESSION; EVIDENCE BASED MEDICINE; GENERAL MENTAL DISEASE ASSESSMENT; HEALTH CARE ORGANIZATION; HEALTH CARE PLANNING; HUMAN; INTERNATIONAL COOPERATION; MEDICAL PROCEDURES; MEDICAL RESEARCH; NON PROFIT ORGANIZATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; PSYCHOTHERAPY; SCREENING; CAREGIVER; CONSENSUS DEVELOPMENT; MEDICAL SOCIETY; MENTAL DISORDERS; PSYCHOLOGY; QUALITY OF LIFE;

CAREGIVERS; CYSTIC FIBROSIS; HUMANS; INTERNATIONAL COOPERATION; MENTAL DISORDERS; PRACTICE GUIDELINES AS TOPIC; QUALITY OF LIFE; SOCIETIES, MEDICAL;

EID: 84958206254     PISSN: 00406376     EISSN: 14683296     Source Type: Journal    
DOI: 10.1136/thoraxjnl-2015-207488     Document Type: Article

References (41)

1. Pinquart M, Shen Y. Depressive symptoms in children and adolescents with chronic physical illness: an updated meta-analysis. J Pediatr Psychol 2011;36:375-84.
2. Moussavi S, Chatterji S, Verdes E, et al. Depression, chronic diseases, and decrements in health: results from the World Health Surveys. Lancet 2007;370:851-8.
3. Mall MA, Elborn JS. ERS monograph: cystic fibrosis. Sheffield, UK: European Respiratory Society, 2014.
4. Sawicki GS, Sellers DE, Robinson WM. High treatment burden in adults with cystic fibrosis: challenges to disease self-management. J Cyst Fibros 2009;8:91-6.
5. Joffres M, Jaramillo A, Dickinson J, et al., Canadian Task Force on Preventative Health. Recommendations on screening for depression in adults. CMAJ 2013;185:775-82.
6. National Collaborating Center for Mental Health. The NICE guideline on the management and treatment of depression in adults (updated edition). Leicester, UK: British Psychological Society, 2010.
7. Cystic Fibrosis Foundation Patient Registry. 2012 Annual Data Report, 2012.
8. American Psychiatric Association, ed. Diagnostic and Statistical Manual of Mental Disorders (DSM-5). 5th edn. American Psychiatric Publishing, Incorporated, 2013.
9. Uman LS, Birnie KA, Noel M, et al. Psychological interventions for needle-related procedural pain and distress in children and adolescents. Cochrane Database Syst Rev 2013;10:CD005179.
10. Smith BA, Modi AC, Quittner AL, et al. Depressive symptoms in children with cystic fibrosis and parents and its effects on adherence to airway clearance. Pediatr Pulmonol 2010;45:756-63.
11. Latchford G, Duff AJ. Screening for depression in a single CF centre. J Cyst Fibros 2013;12:794-6.
12. Havermans T, Colpaert K, Dupont LJ. Quality of life in patients with cystic fibrosis: association with anxiety and depression. J Cyst Fibros 2008;7:581-4.
13. Quittner AL, Goldbeck L, Abbott J, et al. Prevalence of depression and anxiety in patients with cystic fibrosis and parent caregivers: results of the International Depression Epidemiological Study across nine countries. Thorax 2014;69:1090-7.
14. Ploessl C, Pettit RS, Donaldson J. Prevalence of depression and antidepressant therapy use in a pediatric cystic fibrosis population. Ann Pharmacother 2014;48:488-93.
15. Snell C, Fernandes S, Bujoreanu IS, et al. Depression, illness severity, and healthcare utilization in cystic fibrosis. Pediatr Pulmonol 2014;49:1177-81.
16. Hilliard ME, Eakin ME, Borrelli B, et al. Medication beliefs mediate between depressive symptoms and medication adherence in cystic fibrosis. Health Psychol2015;34:496-504.
17. Riekert KA, Bartlett SJ, Boyle MP, et al. The association between depression, lung function, and health-related quality of life among adults with cystic fibrosis. Chest 2007;132:231-7.
18. Robinson KA, Saldanha IJ, McKoy NA. Development of a framework to identify research gaps from systematic reviews. J Clin Epidemiol 2011;64:1325-30.
19. Borowitz D, Robinson KA, Rosenfeld M, et al. Cystic Fibrosis Foundation evidence-based guidelines for management of infants with cystic fibrosis. J Pediatr 2009;155:S73-93.
20. Smyth AR, Bell SC, Bojcin S, et al. European Cystic Fibrosis Society standards of care: best practice guidelines. J Cyst Fibros 2014;13(Suppl 1):S23-42.
21. O'Connell ME, Boat T, Warner KE, eds. Preventing Mental, Emotional, and Behavioral Disorders Among Young People: Progress and Possibilities. Washington DC: National Academies Press, 2009.
22. Abbott J, Elborn S, Georgiopoulos A, et al. Cystic Fibrosis Foundation and European Cystic Fibrosis Society survey of cystic fibrosis mental health care delivery. J Cyst Fibros 2015;14:533-9.
23. U.S. Preventive Services Task Force. Screening for depression in adults: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2009;151:784-92.
24. U.S. Preventive Services Task Force. Screening and treatment for major depressive disorder in children and adolescents: U.S. Preventive Services Task Force recommendation statement. Pediatrics 2009;123:1223-8.
25. Geoffrey RS, Cynthia B, Graham AB III, et al. 2014 recommendations for pediatric preventive health care. Pediatrics 2014;133:568-70.
26. National Collaborating Center for Mental Health. Common Mental Health Disorders: The NICE Guideline on identification and pathways to care. Leicester, UK: The British Psychological Society & The Royal College of Psychiatrists, 2011.
27. National Collaborating Center for Mental Health. Depression in adults with a chronic health problem: treatment and management. Leicester, UK: National Institute for Health and Clinical Excellence, 2009.
28. Andersen B, DeRubeis R, Berman B, et al. Screening, assessment, and care of anxiety and depressive symptoms in adults with cancer: an American Society of Clinical Oncology guideline adaptation. J Clin Oncol 2014;32:1605-19.
29. Posner K, Brown GK, Stanley B, et al. The Columbia-Suicide Severity Rating Scale; initial validity and internal consistency findings from three multisite studies with adolescents and adults. Am J Psychiatry 2011;168:1266-77.
30. Goldbeck L, Fidika A, Herle M, et al. Cochrane corner: psychological interventions for individuals with cystic fibrosis and their families. Thorax 2015;70:1089-91.
31. Blackwell LS, Quittner AL. Daily pain in adolescents with CF: effects on adherence, psychological symptoms, and health-related quality of life. Pediatr Pulmonol 2015;50:244-51.
32. Smith BA, Cogswell A, Garcia G. Vitamin D and depressive symptoms in children with cystic fibrosis. Psychosomatics 2014;55:76-81.
33. Felger JC, Lotrich FE. Inflammatory cytokines in depression: neurobiological mechanisms and therapeutic implications. Neuroscience 2013;246:199-229.
34. Rachman S. The evolution of cognitive behaviour therapy. In: Clark DF, Fairburn CG, Gelder MG, eds. Science and practice of cognitive behaviour therapy. Oxford, UK: Oxford University Press, 1997:1-26.
35. Cornes CL, Frank E. Interpersonal psychotherapy for depression. Clin Psychol 1994;47:9-10.
36. March JS, Vitiello B. Clinical messages from the treatment for adolescents with depression study (TADS). Am J Psychiatry 2009;166:1118-23.
37. Beach SR, Celano CM, Noseworthy PA, et al. QTc prolongation, torsades de pointes, and psychotropic medications. Psychosomatics 2013;54:1-13.
38. Burker EJ, Sedway J, & Carone S. Psychological and educational factors: better predictors of work status than FEV1 in adults with cystic fibrosis. Pediatr Pulmonol 2004;38:413-18.
39. Berk M, Williams LJ, Jacka FN, et al. So depression is an inflammatory disease, but where does the inflammation come from? BMC Med 2013;11:200.
40. Fidika A, Herle M, Lehmann C, et al. A web-based psychological support program for caregivers of children with cystic fibrosis: a pilot study. Health Qual Life Outcomes 2013;11:1-9.
41. Huffman JC, Niazi SK, Rundell JR, et al. Essential articles on collaborative care models for the treatment of psychiatric disorders in medical settings: a publication by the Academy of Psychosomatic Medicine Research and Evidence-Based Practice Committee. Psychosomatics 2014;55:109-22.